| Financial Year |
March 31 2023 |
| Monetary Funds |
50,041,961,223.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
896,751.68 |
| Accounts Receivable |
1,461,630,406.99 |
| Advances to Suppliers |
1,979,805,263.41 |
| Other Receivables |
96,675,231,830.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
905,642,239.68 |
| Inventories |
153,738,806,076.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,261,333,651.31 |
| Other Current Assets |
13,155,698,434.38 |
| Total Current Assets |
319,315,363,638.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
408,259.58 |
| Long-term Equity Investment |
64,065,886,980.22 |
| Investment Properties |
25,842,406,650.11 |
| Fixed Assetes |
757,685,832.40 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,851,695.11 |
| R&D expenses |
-- |
| Goodwill |
336,057,280.07 |
| Long-Term Deferred and Prepaid Expenses |
619,086,244.82 |
| Deferred Income Tax Assets |
5,353,722,954.37 |
| Other Non-Current Assets |
2,336,407,685.00 |
| Sub-Total of Non-Current Assets |
103,232,031,754.01 |
| Total Assets |
422,547,395,392.23 |
| Short-Term Loans |
2,379,261,585.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
464,268,199.26 |
| Accounts Payable |
27,913,011,832.49 |
| Accounts Received In Advance |
302,785,811.75 |
| Employee Compensation Payable |
3,984,207,190.87 |
| Taxes Payable |
3,367,099,581.43 |
| Interest Payable |
-- |
| Dividend Payable |
37,014,604.82 |
| Other payables |
45,654,007,823.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,023,650,783.35 |
| Other Current Liabilities |
7,803,756,050.26 |
| Sub-Total of Current Liabilities |
220,887,403,092.91 |
| Long-term Loans |
62,866,502,486.51 |
| Bonds Payable |
14,708,851,225.41 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,516,000.00 |
| Deferred Income Tax Liabilities |
5,222,053,490.22 |
| Other Non-Current Liabilities |
1,853,008,025.64 |
| Sub-Total of Non-Current Liabilities |
85,706,069,127.78 |
| Total Liabilities |
306,593,472,220.69 |
| Paid-In Capital(Or Share Stock) |
4,514,583,572.00 |
| Capital Surplus |
442,590,520.43 |
| Surplus Reserve |
2,438,452,948.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
57,514,674,765.12 |
| Minority Stockholder's Interest |
50,562,123,666.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
65,391,799,505.49 |
| Owner's Equity（Stockholder's Equity） |
115,953,923,171.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
422,547,395,392.23 |
